home.social

#mdmaassistedtherapy — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #mdmaassistedtherapy, aggregated by home.social.

fetched live
  1. Inside the vaults of Australia’s legal MDMA and psilocybin magic mushroom trade

    Loading… For decades, MDMA, also known as ecstasy or molly, has been traded underground and illegally ingested in…
    #NewsBeep #News #Business #AU #Australia #magicmushrooms #mdma #MDMAassistedtherapy #mushrooms #post-traumaticstressdisorder #psilocybecubensis #psilocybinmushroom #PTSD #therapy #treatment-resistantdepression
    newsbeep.com/au/694322/

  2. Inside the vaults of Australia’s legal MDMA and psilocybin magic mushroom trade

    Loading… For decades, MDMA, also known as ecstasy or molly, has been traded underground and illegally ingested in…
    #NewsBeep #News #Business #AU #Australia #magicmushrooms #mdma #MDMAassistedtherapy #mushrooms #post-traumaticstressdisorder #psilocybecubensis #psilocybinmushroom #PTSD #therapy #treatment-resistantdepression
    newsbeep.com/au/694322/

  3. pubmed.ncbi.nlm.nih.gov/395314 Cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) in chronic and treatment-resistant post-traumatic stress disorder of moderate or higher severity: A health-economic model (Stanicic, et al, 2024) #mdma #mdmaassistedtherapy #mdmaassistedpsychotherapy #psychedelic #psychedelics #mentalhealth #psychedelicmentalhealth

  4. pubmed.ncbi.nlm.nih.gov/395314 Cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) in chronic and treatment-resistant post-traumatic stress disorder of moderate or higher severity: A health-economic model (Stanicic, et al, 2024) #mdma #mdmaassistedtherapy #mdmaassistedpsychotherapy #psychedelic #psychedelics #mentalhealth #psychedelicmentalhealth

  5. pubmed.ncbi.nlm.nih.gov/395314 Cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) in chronic and treatment-resistant post-traumatic stress disorder of moderate or higher severity: A health-economic model (Stanicic, et al, 2024) #mdma #mdmaassistedtherapy #mdmaassistedpsychotherapy #psychedelic #psychedelics #mentalhealth #psychedelicmentalhealth

  6. pubmed.ncbi.nlm.nih.gov/395314 Cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) in chronic and treatment-resistant post-traumatic stress disorder of moderate or higher severity: A health-economic model (Stanicic, et al, 2024) #mdma #mdmaassistedtherapy #mdmaassistedpsychotherapy #psychedelic #psychedelics #mentalhealth #psychedelicmentalhealth

  7. What #psychedelics are available for #psychedelicassistedpsychotherapy now that the #fda rejected one company's application for #mdmaassistedtherapy for #ptsd? Generic, racemic #ketamine with many other molecules in various FDA-approved phases of development for many #mentalhealth indications. For use in collaboration with your medical and mental health care providers. psychedelicmentalhealth.net/wh

  8. What #psychedelics are available for #psychedelicassistedpsychotherapy now that the #fda rejected one company's application for #mdmaassistedtherapy for #ptsd? Generic, racemic #ketamine with many other molecules in various FDA-approved phases of development for many #mentalhealth indications. For use in collaboration with your medical and mental health care providers. psychedelicmentalhealth.net/wh

  9. What #psychedelics are available for #psychedelicassistedpsychotherapy now that the #fda rejected one company's application for #mdmaassistedtherapy for #ptsd? Generic, racemic #ketamine with many other molecules in various FDA-approved phases of development for many #mentalhealth indications. For use in collaboration with your medical and mental health care providers. psychedelicmentalhealth.net/wh

  10. What #psychedelics are available for #psychedelicassistedpsychotherapy now that the #fda rejected one company's application for #mdmaassistedtherapy for #ptsd? Generic, racemic #ketamine with many other molecules in various FDA-approved phases of development for many #mentalhealth indications. For use in collaboration with your medical and mental health care providers. psychedelicmentalhealth.net/wh

  11. pubmed.ncbi.nlm.nih.gov/388969 The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials (Yang, et al, 2024) #mdma #fda #psychedelic #psychedelics #fda #psychedelicresearch #MDMAtherapy #mdmaassistedtherapy #ptsd #psychedelictherapy #psychedelicassistedpsychotherapy #neuroscience #psychiatry #mentalhealth — Adverse effects found not to interfere with efficacy

  12. pubmed.ncbi.nlm.nih.gov/388969 The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials (Yang, et al, 2024) #mdma #fda #psychedelic #psychedelics #fda #psychedelicresearch #MDMAtherapy #mdmaassistedtherapy #ptsd #psychedelictherapy #psychedelicassistedpsychotherapy #neuroscience #psychiatry #mentalhealth — Adverse effects found not to interfere with efficacy

  13. pubmed.ncbi.nlm.nih.gov/388969 The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials (Yang, et al, 2024) #mdma #fda #psychedelic #psychedelics #fda #psychedelicresearch #MDMAtherapy #mdmaassistedtherapy #ptsd #psychedelictherapy #psychedelicassistedpsychotherapy #neuroscience #psychiatry #mentalhealth — Adverse effects found not to interfere with efficacy

  14. pubmed.ncbi.nlm.nih.gov/388969 The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials (Yang, et al, 2024) #mdma #fda #psychedelic #psychedelics #fda #psychedelicresearch #MDMAtherapy #mdmaassistedtherapy #ptsd #psychedelictherapy #psychedelicassistedpsychotherapy #neuroscience #psychiatry #mentalhealth — Adverse effects found not to interfere with efficacy

  15. pubmed.ncbi.nlm.nih.gov/389577 Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System (Makunts, et al, 2024) #mdma #dili #liver #psychedelic #psychedelicresearch #faers #fda #psychedelics #mdmaassistedtherapy — finding in estimated 20 million, perhaps 1 case of liver damage from MDMA, increased risk with poly drug use.

  16. pubmed.ncbi.nlm.nih.gov/389577 Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System (Makunts, et al, 2024) #mdma #dili #liver #psychedelic #psychedelicresearch #faers #fda #psychedelics #mdmaassistedtherapy — finding in estimated 20 million, perhaps 1 case of liver damage from MDMA, increased risk with poly drug use.

  17. pubmed.ncbi.nlm.nih.gov/389577 Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System (Makunts, et al, 2024) #mdma #dili #liver #psychedelic #psychedelicresearch #faers #fda #psychedelics #mdmaassistedtherapy — finding in estimated 20 million, perhaps 1 case of liver damage from MDMA, increased risk with poly drug use.

  18. pubmed.ncbi.nlm.nih.gov/389577 Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System (Makunts, et al, 2024) #mdma #dili #liver #psychedelic #psychedelicresearch #faers #fda #psychedelics #mdmaassistedtherapy — finding in estimated 20 million, perhaps 1 case of liver damage from MDMA, increased risk with poly drug use.

  19. clinicaltrials.gov/study/NCT05 Emory University plans #fda Phase 2 study of #mdma plus a type of behavioral #psychotherapy called Exposure Therapy for the treatment of #ptsd — This study is unrelated to the MAPS/Lykos new drug application for #mdmaassistedtherapy and a reminder #psychedelic #research is robust and ongoing. #studydesign should include blinding with #ketamine and comparison to #cognitivebehavioraltherapy #psychedelics

  20. clinicaltrials.gov/study/NCT05 Emory University plans #fda Phase 2 study of #mdma plus a type of behavioral #psychotherapy called Exposure Therapy for the treatment of #ptsd — This study is unrelated to the MAPS/Lykos new drug application for #mdmaassistedtherapy and a reminder #psychedelic #research is robust and ongoing. #studydesign should include blinding with #ketamine and comparison to #cognitivebehavioraltherapy #psychedelics

  21. clinicaltrials.gov/study/NCT05 Emory University plans #fda Phase 2 study of #mdma plus a type of behavioral #psychotherapy called Exposure Therapy for the treatment of #ptsd — This study is unrelated to the MAPS/Lykos new drug application for #mdmaassistedtherapy and a reminder #psychedelic #research is robust and ongoing. #studydesign should include blinding with #ketamine and comparison to #cognitivebehavioraltherapy #psychedelics

  22. clinicaltrials.gov/study/NCT05 Emory University plans #fda Phase 2 study of #mdma plus a type of behavioral #psychotherapy called Exposure Therapy for the treatment of #ptsd — This study is unrelated to the MAPS/Lykos new drug application for #mdmaassistedtherapy and a reminder #psychedelic #research is robust and ongoing. #studydesign should include blinding with #ketamine and comparison to #cognitivebehavioraltherapy #psychedelics